#EBW25 Previews: State-of-the-art speaker for 4A ‘Clinical biobanks: Bridging research and patient care’
Dr. Tilman Pfeffer, DZIF Tissue Bank, will be the state-of-the-art speaker leading the panel session ‘Clinical biobanks: Bridging research and patient care‘. We have profiled his biography and abstract here.
Dr. Tilman Pfeffer
After his PhD study in the late effects of diabetes mellitus with a focus on diabetic nephropathy, Dr. Tilman Pfeffer started at the Tissue Bank of the German Centre for Infectious Research (DZIF) as a project manager with a central focus on the coordination of the COVID-19 autopsy registry in Baden-Württemberg, Germany.
In late 2023, he took over the position as deputy manager of the DZIF Tissue Bank gaining the opportunity to intensify national (BioMaterialBank Heidelberg, German Biobanking Alliance) and international biobanking contacts (BBMRI-ERIC) and strengthen the cooperation between the DZIF Tissue Bank and the Institute of Pathology Heidelberg.
Furthermore, he is an active member in different biobanking working groups (DZIF biobanking coordination, German Center for Health Research DZG biobanking, working group Tissue of the GBA), supporting research in multiple infectious fields and expanding the DZIF-wide translational infrastructure for bioresources, biodata and digital health (TI BBD).
Abstract: Infectious diseases tissue biobanking and biodata management of the German Center for Infection Research – a key infrastructure for multiple research approaches
The DZIF Tissue Bank, as part of the German Center for Infection Research (DZIF) Translational Infrastructure Bioresources, Biodata and Digital Health (TI-BBD), supports multiple infectious research projects and various studies with biosamples, biodata and the latest technologies.
Located at the Institute of Pathology Heidelberg, the DZIF Tissue Bank has access to >800.000 biosamples in the pathological archive. Its support of >125 infectious research projects results in >40 high-ranked publications since 2013. As accredited for DIN EN ISO 20387, the DZIF Tissue Bank is the central national infectious disease tissue biobank. The offered services (biosample-storage, IHC, IF, chemical stainings, Tissue-Micro-Array assembly, nucleotide extraction) follow SOPs and therefore guarantee a maximum of quality, safety, and reproducibility. In addition, consulting, training and connecting biobanking
services with state-of-the-art biodata processing facilities in the DZIF TI-BBD are of particular importance.
Significant achievements encompass the contribution, coordination and full integration of the unique COVID-19 autopsy registry in Baden-Württemberg, Germany, into the DZIF Tissue Bank, where we store over 12.000 COVID-19 biosamples (cryo and FFPE) and maintain the specifically established web-based autopsy registry. Furthermore, significances of invasive fungal infection (IFI) in organ transplantation (together with the transplantcohort of DZIF) are investigated.
Quality assured tissue biobanking as by DZIF Tissue Bank, is a relevant central national research infrastructure and significantly contributes to infectious research. The DZIF Tissue Bank enhances the efficiency of biobanking for infectious diseases research and as part of the DZIF TI-BBD, its biosamples and metadata management are of high relevance.
Session details
- Date: Wednesday 14 May
- Time: 17:30-19:00